课题基金 / 基金详情

Colon cancer therapy targeting specific charactetistics of tumor vessel.

Colon cancer therapy targeting specific charactetistics of tumor vessel.
针对肿瘤血管特定特征的结肠癌治疗。
批准号:
16591366
负责人:
YAMADA Kyoji
金额:
$1.6万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

YAMADA Kyoji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Since it have been reported that angiogenesis plays an important role in cancer growth, various studies and therapies for tumor angiogenesis have been done. If specific charactetistics of tumor vessel find out, more effective atiangiogenic therapies may be put into practice. The tumor vessel is large and small, twisting, winding and leacky compared with normal vessel. This alterations may be caused by too much proliferative activity or unbalance of angiogenic factors in cancer tissues. We focus on Angiopoietin2/Angiopoietin1 balance, Alteration of this balance in experimental cancerous angiogenesis were examined with antiangiogenic effect of argatroban (new anticoagulant). Macroscopical Vascular structure, Count of vascular area, CD34microvessel density, angiogenic factor (Ang1,Ang2,VEGF) were measured in dorsal air sac model using S-180 sarcoma cell and COLO320DM colon cancer cell. Tube formation of HUVEC cells were tested by Matrigel. For adiministration of argatroban, tumor angiogenesis was statistically inhibited. Because Argatroban did not inhibited tube formation of HUVEC in martigel assey, this effect may not be direct action for endotherial cells. In this experiment model, the Ang2 to Ang1 ratio was always elevated during tumor angiogenesis, this phenomenon might caused abnormal tumor vasclular artitecture. These results suggest that Argatroban may have antitumor effect by inhibition of tumor angiogenesis. In addition, Rivision of Ang2/Ang1 ratio may related to antiangiogenic effect in cancer tissues.Focus on abnormal Nitric oxide synthesis of tumor vessel, Another experiment was done. In the same dorsal air sac model, N^G-nitro-L-arginine-methyl-ester (L-NAME), a NO synthase inhibitor was tested its anti-angiogenic effect with relationship between angiogenic growth factors. Administration of L-NAME significantly inhibited tumor angiogenesis. VEGF expression and mRNA levels in tissue surrounding tumor cells were significantly decreased.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Anti-angiogenic Effect of Argatroban and Angiopoietin1/2 Balance in Experimental Cancerous Angiogenesis
阿加曲班和血管生成素1/2平衡在实验性癌性血管生成中的抗血管生成作用
DOI: --
发表时间: 2005
期刊: 聖マリアンナ医科大学雑誌 32巻5号
影响因子: --
作者: [北川雄光, 他, Aoki K]
通讯作者: Aoki K
L-NAME Inhibts Colon Cancer Cell-induced Angiogenesis amd VEGF production
L-NAME 抑制结肠癌细胞诱导的血管生成和 VEGF 产生
DOI: --
发表时间: 2005
期刊: St. Marianna Med. J. 33
影响因子: --
作者: [北川雄光, 他, Toshiyuki Suwa et al.]
通讯作者: Toshiyuki Suwa et al.
An attempt to develop a novel system for transforming a wide variety of plant species without using the genetic recombination technique.
  • 批准号:
    25660002
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.58万
  • 财政年份:
    2013
  • 负责人:
    YAMADA Kyoji
  • 依托单位:
Enhancement of Vitamin E Level in Oilseeds through Metabolic Engineering.
  • 批准号:
    14360003
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.28万
  • 财政年份:
    2002
  • 负责人:
    YAMADA Kyoji
  • 依托单位:
Cellular and Molecular Breeding of Sesame.
  • 批准号:
    09660003
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.05万
  • 财政年份:
    1997
  • 负责人:
    YAMADA Kyoji
  • 依托单位:
Expression of DNA Topoisomerase II alpha and clinical significance in colon cancer.
  • 批准号:
    08671491
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.47万
  • 财政年份:
    1996
  • 负责人:
    YAMADA Kyoji
  • 依托单位:
海外基金